{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T21:01:09Z","timestamp":1768338069580,"version":"3.49.0"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"DOI":"10.3389\/fcell.2023.1298956","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:34:30Z","timestamp":1697441670000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Editorial: Methods and advances in induced pluripotent stem cells\u2014ophthalmology"],"prefix":"10.3389","volume":"11","author":[{"given":"Lyle","family":"Armstrong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majlinda","family":"Lako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"key":"B1","volume-title":"Preferred practice pattern of primary open angle glaucoma","year":"1996"},{"key":"B2","doi-asserted-by":"publisher","first-page":"11828","DOI":"10.1038\/s41598-020-68811-8","article-title":"Dual SMAD inhibition and Wnt inhibition enable efficient and reproducible differentiations of induced pluripotent stem cells into retinal ganglion cells","volume":"10","author":"Chavali","year":"2020","journal-title":"Sci. Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13287-022-03233-z","article-title":"Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity","volume":"14","author":"Chen","year":"2023","journal-title":"Stem Cell. Res. Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41433-018-0061-z","article-title":"Cellular regeneration strategies for macular degeneration: past, present and future","volume":"32","author":"Chichagova","year":"2018","journal-title":"Eye (Lond)."},{"key":"B5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","article-title":"Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1002\/stem.2883","article-title":"Human-induced pluripotent stem cells generate light responsive retinal organoids with variable and nutrient-dependent efficiency","volume":"36","author":"Hallam","year":"2018","journal-title":"Stem Cells"},{"key":"B7","article-title":"Wet age-related macular degeneration (wet AMD)","volume-title":"StatPearls","author":"Hobbs","year":"2022"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/9780470151808.sc01h08s32","article-title":"Generation of highly enriched populations of optic vesicle-like retinal cells from human pluripotent stem cells","volume":"32","author":"Ohlemacher","year":"2015","journal-title":"Curr. Protoc. Stem Cell. Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.omtm.2021.03.004","article-title":"Transplantation of miPSC\/mESC-derived retinal ganglion cells into healthy and glaucomatous retinas","volume":"21","author":"Oswald","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B10","volume-title":"World development report 1993","year":"1993"},{"key":"B11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/joa.13768","article-title":"Retinal organoids provide unique insights into molecular signatures of inherited retinal disease throughout retinogenesis","volume":"243","author":"Watson","year":"2023","journal-title":"J. Anat."},{"key":"B12","doi-asserted-by":"publisher","first-page":"101162","DOI":"10.1016\/j.isci.2020.101162","article-title":"Strategies for genetically engineering hypoimmunogenic universal pluripotent stem cells","volume":"23","author":"Zhao","year":"2020","journal-title":"iScience"},{"key":"B13","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1038\/ncomms5047","article-title":"Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs","volume":"5","author":"Zhong","year":"2014","journal-title":"Nat. Commun."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2023.1298956\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:34:34Z","timestamp":1697441674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2023.1298956\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":13,"alternative-id":["10.3389\/fcell.2023.1298956"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2023.1298956","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,16]]},"article-number":"1298956"}}